• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcareBiotechnology & Medical ResearchAcorda Therapeutics
    Picture of Acorda Therapeutics logo

    ACORQ — Acorda Therapeutics News Story

    $0.010.000.00%
    us flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro CapNeutral
    • Market Cap
      $0.02m
    • Enterprise Value
      $182.13m
    • Revenue
      $117.63m
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • ACORQ Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    ACORQ Dividends
    All News

    NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:37 AM

    Picture of Acorda Therapeutics logoAcorda Therapeutics
    20/10/2020 14:37
    NASDAQ TRADE HALT  ACOR.O  VOLATILITY TRADING PAUSE AT 09:37 AM
    

    Recent news on Acorda Therapeutics

    See all news
    • Brief: Acorda TherapeuticsCourt Held Hearing To Consider Approval Of Sale Of Substantially All Of Co's Assets To Merz Pharmaceuticals Under Asset Sale

      12/06/2024 22:37
    • Brief: Acorda Says Debtors Did Not Receive More Than One Qualified Bid Before Bid Deadline, In Connection With Chapter 11 Proceedings

      04/06/2024 21:54
    • Live Markets: Biotech companies in 'Darwinian' world as cash remains king

      03/06/2024 18:03
    • U.S. FDA declines to approve Supernus' drug-device combination for Parkinson's disease (updated)

      08/04/2024 13:21
    • U.S. FDA declines to approve Supernus' drug-device combination for Parkinson's disease

      08/04/2024 13:03

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.